Clinical Trial Update: Study of HX008 for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for HX008 in BCG-unresponsive non-muscle invasive bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• HX008

Snippet

Sponsor: Taizhou Hanzhong biomedical co. LTD | Conditions: Bladder Cancer | Phase 2 | Status: UNKNOWN